Product NDC: | 68289-008 |
Proprietary Name: | Cephalexin |
Non Proprietary Name: | Cephalexin |
Active Ingredient(s): | 125 mg/5mL & nbsp; Cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68289-008 |
Labeler Name: | Jazeera Pharmaceutical |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065444 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090901 |
Package NDC: | 68289-008-20 |
Package Description: | 200 mL in 1 BOTTLE (68289-008-20) |
NDC Code | 68289-008-20 |
Proprietary Name | Cephalexin |
Package Description | 200 mL in 1 BOTTLE (68289-008-20) |
Product NDC | 68289-008 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cephalexin |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20090901 |
Marketing Category Name | ANDA |
Labeler Name | Jazeera Pharmaceutical |
Substance Name | CEPHALEXIN ANHYDROUS |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |